Label: BENZEPRO- benzoyl peroxide cloth

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated January 19, 2022

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Rx Only

  • DESCRIPTION

    BenzePrO® Foaming Cloths are a topical preparation containing 6.0% benzoyl peroxide. Each gram of BenzePrO® Foaming Cloths wash contains 60 mg of Benzoyl Peroxide as micronized particles. Ingredients include Purified Water, Carbomer 1342, Sodium Hyaluronate, Cetyl Alcohol, Glycerine, Hydroxypropyl Methylcellulose, Sodium Cocoyl Isethionate, Sodium Methyl Cocoyl Taurate, Sodium Lauryl Sulfoacetate and Disodium Laureth Sulfosuccinate, Sodium PCA, Sodium Hydroxide 10% Solution, Zinc Lactate, Citric Acid, Sodium Citrate, Benzoyl Peroxide 6.0%, Docusate Sodium.

    Benzoyl peroxide is an oxidizing agent that possesses antibacterial properties and is classified as a keratolytic. Benzoyl peroxide (C14H10O4) is represented by the following structure:

    Chemical Structure
  • CLINICAL PHARMACOLOGY

    The exact method of action of benzoyl peroxide in acne vulgaris is not known. Benzoyl peroxide is an antibacterial agent with demonstrated activity against Propionibacterium acnes. This action, combined with the mild keratolytic effect of benzoyl peroxide, is believed to be responsible for its usefulness in acne. Benzoyl peroxide is absorbed by the skin where it is metabolized to benzoic acid and excreted as benzoate in the urine.

  • INDICATIONS AND USAGE

    BenzePrO® Foaming Cloths are indicated for use in the topical treatment of mild to moderate acne vulgaris.

  • CONTRAINDICATIONS

    BenzePrO® Foaming Cloths should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the product. Discontinue use if hypersensitivity is observed.

  • WARNINGS

    FOR EXTERNAL USE ONLY. Not For Ophthalmic Use. Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

    When using this product, skin irritation and dryness is more likely to occur if:

    • you leave BenzePrO® Foaming Cloths on your skin longer than directed
    • you use another topical acne medication at the same time

    Do not use this product if you:

    • have very sensitive skin
    • are sensitive to benzoyl peroxide

    When using this product:

    • avoid unnecessary sun exposure and use a sunscreen
    • avoid contact with the eyes, lips, mouth
    • avoid contact with hair and dyed fabrics, which may be bleached by this product
    • skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in lower concentration.

    Stop use and ask a doctor:

    • if irritation becomes severe.
  • PRECAUTIONS

    General

    If severe irritation develops, discontinue use and institute appropriate therapy.

    Information for patients

    This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. Avoid contact with eyes, eyelids, lips, and mucous membranes. If accidental contact occurs, rinse with water. If excessive redness or irritation develops, discontinue use and consult your physician.

    Carcinogenesis, Mutagenesis, Impairment of Fertility

    Based upon all available evidence, benzoyl peroxide is not considered to be a carcinogen. However, data from a study using mice known to be highly susceptible to cancer suggest that benzoyl peroxide acts as a tumor promoter. The clinical significance of the findings is not known.

    Pregnancy

    Category C animal reproduction studies have not been conducted with benzoyl peroxide. It is also not known whether benzoyl peroxide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzoyl peroxide should be used by a pregnant woman only if clearly needed.

    Nursing Mothers

    It is not known whether this drug is excreted in the human milk. Because many drugs are excreted in human milk, caution should be exercised when benzoyl peroxide is administered to a nursing woman.

    Pediatric Use

    Safety and effectiveness in children below the age of 12 have not been established.

  • ADVERSE REACTIONS

    Allergic contact dermatitis and dryness have been reported with topical benzoyl peroxide therapy.

  • OVERDOSAGE

    If excessive scaling, erythema or edema occurs, the use of this preparation should be discontinued. To hasten resolution of the adverse effects, cool compresses may be used. After symptoms and signs subside, a reduced dosage schedule may be cautiously tried if the reaction is judged to be due to excessive use and not allergenicity.

  • DIRECTIONS

    Avoid contact with hair, fabrics or carpeting as benzoyl peroxide will cause bleaching or discoloration.

    Wash affected areas once or twice daily, or as directed by your physician.

    1. Wet face with water.
    2. Wet cloth with a little waterand work into a full lather.
    3. Cleanse face with cloth for 10-20 seconds avoiding eyes.
    4. Rinse thoroughly and pat dry.
    5. Throw away cloth. Do not flush.
    • If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.
  • HOW SUPPLIED

    BenzePrO® Foaming Cloths are supplied in a carton containing 60 × 3.2 g individually wrapped benzoyl peroxide 6% foaming cloths (NDC 42546-016-60).

    Store at room temperature: 15° - 25°C (59° - 77°F). Protect from freezing.

  • SPL UNCLASSIFIED SECTION

    Manufactured for:
    PruGen Pharmaceuticals
    18899 N Thompson Peak Pkwy
    Scottsdale, AZ 85255
    www.prugen.com

    Rev. 3.0

  • PRINCIPAL DISPLAY PANEL - 60 Cloth Packet Carton

    NDC 42546-016-60
    Rx only

    BenzePrO®

    Foaming Cloths
    benzoyl peroxide 6.0%

    60
    cloths
    Net wt. 3.2 g each

    PRUGEN
    PHARMACEUTICALS

    PRINCIPAL DISPLAY PANEL - 60 Cloth Packet Carton
  • INGREDIENTS AND APPEARANCE
    BENZEPRO 
    benzoyl peroxide cloth
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42546-016
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Benzoyl Peroxide (UNII: W9WZN9A0GM) (Benzoyl Peroxide - UNII:W9WZN9A0GM) Benzoyl Peroxide60 mg
    Inactive Ingredients
    Ingredient NameStrength
    water (UNII: 059QF0KO0R)  
    Carbomer Copolymer Type B (Allyl Pentaerythritol Crosslinked) (UNII: 809Y72KV36)  
    Hyaluronate Sodium (UNII: YSE9PPT4TH)  
    Cetyl Alcohol (UNII: 936JST6JCN)  
    Glycerin (UNII: PDC6A3C0OX)  
    HYPROMELLOSE 2910 (15 MPA.S) (UNII: 36SFW2JZ0W)  
    Sodium Cocoyl Isethionate (UNII: 518XTE8493)  
    Sodium Methyl Cocoyl Taurate (UNII: JVL98CG53G)  
    Sodium Lauryl Sulfoacetate (UNII: D0Y70F2B9J)  
    Disodium Laureth Sulfosuccinate (UNII: D6DH1DTN7E)  
    Sodium Pyrrolidone Carboxylate (UNII: 469OTG57A2)  
    Sodium Hydroxide (UNII: 55X04QC32I)  
    Zinc Lactate (UNII: 2GXR25858Y)  
    Citric Acid Monohydrate (UNII: 2968PHW8QP)  
    Sodium Citrate, Unspecified Form (UNII: 1Q73Q2JULR)  
    Docusate Sodium (UNII: F05Q2T2JA0)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:42546-016-6060 in 1 CARTON08/01/2015
    11 in 1 PACKET; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    UNAPPROVED DRUG OTHER08/01/2015
    Labeler - PruGen, Inc. (929922750)
    Establishment
    NameAddressID/FEIBusiness Operations
    Span Packing Services557434805MANUFACTURE(42546-016)